OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$7.59M

FY 2025 · Annual

Investing Cash Flow

-$82.67M

FY 2025 · Annual

Financing Cash Flow

$39.33M

FY 2025 · Annual

-63.5% YoY

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
Deferred Income Tax42.21M(88K)(3.62M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(5.52M)27.02M13.16M
Other Non-Cash Items776K(29M)155.33M15.09M12.47M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(7.59M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(17.05M)
Acquisitions (Net)(2.54M)(11.06M)1.03M257K(65.62M)
Purchases of Investments(120.02M)(15M)(10M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M49.4M3.52M2.5M
Other Investing Activities(31.08M)4.29M(8.65M)(7.97M)(1.52M)
Investing Cash Flow(115.11M)44.03M1.36M(38.77M)(82.67M)
Debt Repayment(116.4M)(1.01M)(87K)(786K)(60K)
Common Stock Issued284.88M6.34M20K108.56M41.18M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(750K)6K(1.79M)
Financing Cash Flow174.46M5.33M(817K)107.78M39.33M
Effect of Forex Changes0000313K
Net Change in Cash30.77M13.15M(34.65M)72.88M(49.01M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(24.64M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$24.8M
+ D&A$18.0M
+ Stock-Based Comp$4.2M
- Deferred Tax-$13.8M
- Working Capital-$2.1M
+ Other Non-Cash$12.5M
= Operating Cash Flow-$7.6M
- Capex-$17.0M
= Free Cash Flow-$24.6M

Analysis

FY2025 free cash flow is -$24.6M. FCF conversion is 99.5% of net income. Operating cash flow was -$7.6M, with capex of -$17.0M. The largest bridge item is D&A at $18.0M.

Recent Filings

Recent regulatory filings

No filings found.

Does OGI.TO generate free cash flow?

OrganiGram Holdings Inc. (OGI.TO) generated -$24.64M of free cash flow in fiscal 2025.

How much operating cash flow does OGI.TO produce?

Operating cash flow was -$7.59M, before capital expenditures of $17.05M.